We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
-14.85%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$637M
AUM Growth
-$214M
Cap. Flow
-$70.8M
Cap. Flow %
-11.11%
Top 10 Hldgs %
18.21%
Holding
581
New
183
Increased
73
Reduced
207
Closed
105

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$14.4M
2
NFLX icon
Netflix
NFLX
+$9.91M
3
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$8M
4
TDOC icon
Teladoc Health
TDOC
+$7.16M
5
CIEN icon
Ciena
CIEN
+$6.16M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.1M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10M
3
BIIB icon
Biogen
BIIB
+$8.82M
4
BABA icon
Alibaba
BABA
+$8.42M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.33M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Healthcare 20.95%
3 Industrials 11.87%
4 Financials 8.28%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOP icon
526
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.66B
– –
-1,378
Closed -$239K
ZS icon
527
Zscaler
ZS
$28.8B
– –
-28,844
Closed -$1.18M
TECX
528
Tectonic Therapeutic
TECX
$707M
– –
-3,433
Closed -$2.14M
NVRO
529
DELISTED
NEVRO CORP.
NVRO
– –
-11,473
Closed -$654K
ITCI
530
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-33,384
Closed -$724K
RVNC
531
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-87,355
Closed -$2.17M
AKTS
532
DELISTED
Akoustis Technologies Inc
AKTS
– –
-94,909
Closed -$747K
KA
533
DELISTED
Kineta, Inc. Common Stock
KA
– –
-692
Closed -$234K
SPLK
534
DELISTED
Splunk Inc
SPLK
– –
-18,730
Closed -$2.27M
IMGN
535
DELISTED
Immunogen Inc
IMGN
– –
-61,676
Closed -$584K
MRTX
536
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-5,729
Closed -$270K
INFI
537
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-364,401
Closed -$988K
APTX
538
DELISTED
Aptinyx Inc. Common Stock
APTX
– –
-11,269
Closed -$326K
AUY
539
DELISTED
Yamana Gold, Inc.
AUY
– –
-400,000
Closed -$996K
ATNX
540
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-3,150
Closed -$979K
CLVS
541
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-35,996
Closed -$1.06M
GBT
542
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-13,825
Closed -$525K
EMWP
543
DELISTED
Eros Media World PLC
EMWP
– –
-1,378
Closed -$332K
COHR
544
DELISTED
Coherent Inc
COHR
– –
-3,676
Closed -$633K
GWPH
545
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-8,938
Closed -$1.54M
NEOS
546
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-285,716
Closed -$1.39M
DLPH
547
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$0 ﹤0.01%
+1
New +$19
MNTA
548
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-12,533
Closed -$330K
FSCT
549
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
-10,783
Closed -$407K
RARX
550
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-34,453
Closed -$623K
19 20 21
22
23

Similar funds

BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $636M AUM 39.33% 1-Year Est. Return
FTC
Farmers Trust Company Youngstown, Ohio $637M AUM 23.14% 1-Year Est. Return

Essex Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Essex Investment Management held 581 positions worth $637M, down 25% from $851M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Essex Investment Management withdrew a net $70.8M in Q4 2018, closing 105 positions and reducing 207 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $5.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Essex Investment Management opened a new position in NVIDIA worth $10.1M.

  • Essex Investment Management's largest Q4 2018 buy was NVIDIA: 3,018,520 shares worth $10.1M.
  • Essex Investment Management added most to VanEck Junior Gold Miners ETF in Q4 2018, an estimated $8M increase.
  • Essex Investment Management's biggest Q4 2018 reduction was Apple, cutting an estimated $10.1M.
  • Essex Investment Management fully exited Regeneron Pharmaceuticals in Q4 2018, selling an estimated $5.1M.
  • Essex Investment Management's ten largest holdings make up 18% of its $637M portfolio in Q4 2018.
  • Essex Investment Management opened 183 new positions and closed 105 in Q4 2018.
  • Essex Investment Management's portfolio value fell 25% quarter-over-quarter to $637M.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.